These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25914186)

  • 1. Mortality in myasthenia gravis: A nationwide population-based follow-up study in Denmark.
    Hansen JS; Danielsen DH; Somnier FE; Frøslev T; Jakobsen J; Johnsen SP; Andersen H
    Muscle Nerve; 2016 Jan; 53(1):73-7. PubMed ID: 25914186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
    Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS
    J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
    Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
    Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
    Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
    Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients.
    Jitpimolmard S; Taimkao S; Chotmongkol V; Sawanyawisuth K; Vincent A; Newsom-Davis J
    J Med Assoc Thai; 2006 Jan; 89(1):68-71. PubMed ID: 16583584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime course of myasthenia gravis.
    Grob D; Brunner N; Namba T; Pagala M
    Muscle Nerve; 2008 Feb; 37(2):141-9. PubMed ID: 18059039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.
    Pedersen EG; Hallas J; Hansen K; Jensen PE; Gaist D
    Eur J Neurol; 2013 Feb; 20(2):309-14. PubMed ID: 22882327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mortality and related factors in 2195 adult myasthenia gravis patients in a 10-year follow-up study.
    Liu C; Wang Q; Qiu Z; Lin J; Chen B; Li Y; Gui M; Zhang M; Yang M; Wang W; Bu B
    Neurol India; 2017; 65(3):518-524. PubMed ID: 28488612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
    Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
    S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece.
    Tsiamalos P; Kordas G; Kokla A; Poulas K; Tzartos SJ
    Eur J Neurol; 2009 Aug; 16(8):925-30. PubMed ID: 19374661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AChR-myasthenia gravis switching to double-seropositive several years after the onset.
    Zouvelou V; Zisimopoulou P; Psimenou E; Matsigkou E; Stamboulis E; Tzartos SJ
    J Neuroimmunol; 2014 Feb; 267(1-2):111-2. PubMed ID: 24388224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
    J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J; Maida EM; Mamoli B; Mayr N
    Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and follow-up management of 135 children with myasthenia gravis].
    Yang ZX; Xiong H; Zhang YH; Bao XH; Jiang YW; Wu Y; Wang S; Chang XZ; Qin J; Lin Q; Wu XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):455-9. PubMed ID: 21681282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis.
    Somnier FE
    Dan Med Bull; 1996 Feb; 43(1):1-10. PubMed ID: 8906977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seronegative myasthenia gravis: disease severity and prognosis.
    Romi F; Aarli JA; Gilhus NE
    Eur J Neurol; 2005 Jun; 12(6):413-8. PubMed ID: 15885043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.
    Ambrogi V; Mineo TC
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):601-6. PubMed ID: 22177829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
    Chan KH; Lachance DH; Harper CM; Lennon VA
    Muscle Nerve; 2007 Nov; 36(5):651-8. PubMed ID: 17654558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.